glucagon

FDA Drug Profile — Baqsimi, Glucagon

glucagon is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including Baqsimi, Glucagon. Available dosage forms: powder, kit.

Drug Details

Generic Name
glucagon
Brand Names
Baqsimi, Glucagon
Application Number
NDA210134
Sponsor
Amphastar Pharmaceuticals, Inc.
NDC Codes
6
Dosage Forms
POWDER, KIT
Routes
NASAL
Active Ingredients
GLUCAGON

Indications and Usage

1 INDICATIONS AND USAGE Glucagon for Injection is an antihypoglycemic agent and a gastrointestinal motility inhibitor indicated: for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ( 1.1 ) as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients ( 1.2 ) 1.1 Severe Hypoglycemia Glucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. 1.2 Diagnostic Aid Glucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.